169 related articles for article (PubMed ID: 21996344)
1. Neuroprotective activities of regulatory T cells.
Gendelman HE; Appel SH
Trends Mol Med; 2011 Dec; 17(12):687-8. PubMed ID: 21996344
[No Abstract] [Full Text] [Related]
2. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.
Machhi J; Kevadiya BD; Muhammad IK; Herskovitz J; Olson KE; Mosley RL; Gendelman HE
Mol Neurodegener; 2020 Jun; 15(1):32. PubMed ID: 32503641
[TBL] [Abstract][Full Text] [Related]
3. Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia.
Motataianu A; Barcutean L; Balasa R
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):159-166. PubMed ID: 31903792
[TBL] [Abstract][Full Text] [Related]
4. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
Appel SH; Beers DR; Henkel JS
Trends Immunol; 2010 Jan; 31(1):7-17. PubMed ID: 19879804
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis.
Rashid Chehreh Bargh S; Tafakhori A; Masoumi F; Rahmani F; Ahmadi M; Namdar A; Azimi M; Tavasolian P; Habibi S; Zamani B; Maserrat M; Sadr M; Noorbakhsh F; Rezaei N
Ir J Med Sci; 2018 Nov; 187(4):1065-1071. PubMed ID: 29574662
[TBL] [Abstract][Full Text] [Related]
6. A gene therapy approach for the treatment of amyotrophic lateral sclerosis and Parkinson's disease.
Zurn AD; Tseng JL; Déglon N; Joseph JM; Aebischer P
Adv Pharmacol; 1998; 42():929-31. PubMed ID: 9328050
[No Abstract] [Full Text] [Related]
7. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.
Beers DR; Henkel JS; Zhao W; Wang J; Huang A; Wen S; Liao B; Appel SH
Brain; 2011 May; 134(Pt 5):1293-314. PubMed ID: 21596768
[TBL] [Abstract][Full Text] [Related]
8. Histocompatibility antigens in amyotrophic lateral sclerosis and parkinsonism-dementia on Guam.
Hoffman PM; Robbins DS; Gibbs CJ; Gajdusek DC; Garruto RM; Terasaki OI
Lancet; 1977 Oct; 2(8040):717. PubMed ID: 71524
[No Abstract] [Full Text] [Related]
9. Lymphocyte transformation study of Guamanian patients with amyotrophic lateral sclerosis and Parkinsonism-dementa.
Nemo GJ; Brody JA; Cruz M
Neurology; 1974 Jun; 24(6):579-81. PubMed ID: 4857553
[No Abstract] [Full Text] [Related]
10. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
11. Stem cells for Parkinson disease and ALS: replacement or protection?
Svendsen CN; Langston JW
Nat Med; 2004 Mar; 10(3):224-5. PubMed ID: 14991036
[No Abstract] [Full Text] [Related]
12. Cellular immunity in Guamanians with amyotrophic lateral sclerosis and Parkinsonism-dementia.
Hoffman PM; Robbins DS; Nolte MT; Gibbs CJ; Gajdusek DC
N Engl J Med; 1978 Sep; 299(13):680-5. PubMed ID: 308183
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival.
Henkel JS; Beers DR; Wen S; Rivera AL; Toennis KM; Appel JE; Zhao W; Moore DH; Powell SZ; Appel SH
EMBO Mol Med; 2013 Jan; 5(1):64-79. PubMed ID: 23143995
[TBL] [Abstract][Full Text] [Related]
14. PatientsLikeMe and the tale of three brothers.
Trevena LJ
Med J Aust; 2011 Sep; 195(5):258-9. PubMed ID: 21895584
[No Abstract] [Full Text] [Related]
15. Neurologic degenerative disorders.
Ross AP
Nurs Clin North Am; 1999 Sep; 34(3):725-42. PubMed ID: 10433655
[TBL] [Abstract][Full Text] [Related]
16. A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.
Alsuliman A; Appel SH; Beers DR; Basar R; Shaim H; Kaur I; Zulovich J; Yvon E; Muftuoglu M; Imahashi N; Kondo K; Liu E; Shpall EJ; Rezvani K
Cytotherapy; 2016 Oct; 18(10):1312-24. PubMed ID: 27497700
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells for amyotrophic lateral sclerosis/motor neuron disease: A clinical and preclinical systematic review.
Rajabinejad M; Ranjbar S; Afshar Hezarkhani L; Salari F; Gorgin Karaji A; Rezaiemanesh A
J Cell Physiol; 2020 Jun; 235(6):5030-5040. PubMed ID: 31788795
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.
Zhao W; Beers DR; Liao B; Henkel JS; Appel SH
Neurobiol Dis; 2012 Dec; 48(3):418-28. PubMed ID: 22820142
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis.
Thonhoff JR; Simpson EP; Appel SH
Curr Opin Neurol; 2018 Oct; 31(5):635-639. PubMed ID: 30048339
[TBL] [Abstract][Full Text] [Related]
20. The Role of Regulatory T Lymphocytes in Amyotrophic Lateral Sclerosis.
Beers DR; Zhao W; Appel SH
JAMA Neurol; 2018 Jun; 75(6):656-658. PubMed ID: 29507936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
